Cleveland Clinic: International Clinical Trial Finds That Semaglutide Reduced Cardiovascular Events by 20% in Adults With Overweight or Obesity Who Don't Have Diabetes
November 13, 2023
November 13, 2023
CLEVELAND, Ohio, Nov. 13 (TNSres) -- The Cleveland Clinic issued the following news release on Nov. 11, 2023:
* * *
SELECT trial presented by Cleveland Clinic physician at the American Heart Association's Scientific Sessions 2023
* * *
Findings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and establi . . .
* * *
SELECT trial presented by Cleveland Clinic physician at the American Heart Association's Scientific Sessions 2023
* * *
Findings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and establi . . .